Skip to main content

Personalized liposomal cancer vaccines within days by rapid formulation screening

Project description

Immunotherapy administration via microneedles

Different routes of administration may be used to achieve either systemic or local delivery of therapeutic drugs. The intravenous route of administration bypasses the need for absorption and achieves 100 % bioavailability and rapid action. At the same time, systemic delivery is associated with adverse effects such as toxicity. The EU-funded Need2immune project is interested to improve the delivery of immunotherapeutic drugs against tumours. Researchers will employ microneedles traditionally used in vaccination strategies to deliver drugs via the intradermal or transdermal route. Advantages of such an approach include attaining higher drug concentration at desired sites, for example closer to tumours, and thus increased efficacy.


Net EU contribution
€ 162 806,40
Marie-curie-str. 1
53359 Rheinbach

See on map

Nordrhein-Westfalen Köln Rhein-Sieg-Kreis
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Other funding
€ 162 806,40